MEAKSS, a synthetic peptide, is emerging as a promising treatment for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates remarkable neuroprotective effects by regulating key cellular pathways involved in neuronal survival. Studies suggest that MEAKSS can promote neuronal growth, {reduceneurotoxicity, and augment c